Summer Stanton
Physician Assistant · Omaha, NENPI 1023505815
Payments from drug & device makers
Across 201 payments — averaging $20.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- 180 Medical, Inc.$411
- Johnson & Johnson$398
- AbbVie$332
- Accord Healthcare, Inc.$291
- Teleflex LLC$269
- Urogen Pharma, Inc.$212
- plus $2K from 31 others
What the payments were for
- Food & beverage$4,151100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| 180 Medical, Inc. | 20 | $411 |
| Johnson & Johnson | 24 | $398 |
| AbbVie | 18 | $332 |
| Accord Healthcare, Inc. | 7 | $291 |
| Teleflex LLC | 7 | $269 |
| Urogen Pharma, Inc. | 12 | $212 |
| Pfizer | 12 | $201 |
| Merck | 12 | $199 |
| Sumitomo Pharma America, Inc. | 10 | $180 |
| Tolmar, Inc. | 8 | $163 |
| Dendreon Pharmaceuticals LLC | 6 | $143 |
| Ferring Pharmaceuticals Inc. | 5 | $135 |
| Bayer | 7 | $134 |
| Astellas Pharma US Inc | 5 | $118 |
| Myovant Sciences Inc. | 6 | $98 |
| Boston Scientific | 4 | $96 |
| Verity Pharmaceuticals Inc. | 4 | $78 |
| Procept Biorobotics Corporation | 3 | $74 |
| Coloplast | 3 | $65 |
| Progenics Pharmaceuticals, Inc. | 3 | $59 |
| Tolmar Pharmaceuticals, Inc. | 3 | $52 |
| Urovant Sciences Inc | 3 | $47 |
| Antares Pharma, Inc. | 2 | $42 |
| Axonics, Inc. | 2 | $40 |
| Convatec Inc. | 1 | $38 |
| C. R. Bard, Inc. & Subsidiaries | 2 | $34 |
| Blue Earth Diagnostics | 2 | $33 |
| BD | 1 | $30 |
| Applied Medical Resources Corporation | 1 | $29 |
| Rochester Medical Corporation | 1 | $27 |
| Civco Medical Instruments | 1 | $23 |
| Endo USA, Inc. | 1 | $22 |
| Immunitybio, Inc. | 1 | $21 |
| Novartis | 1 | $18 |
| Photocure Inc | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$144
How this compares
$4,151 in reported general payments places this provider in the 90th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 52 | $34,167 |
| GemtesaVibegron | 23 | $14,405 |
| PremarinEstrogens, Conjugated | 28 | $12,061 |
| Tolterodine Tartrate ErTolterodine Tartrate | 56 | $4,752 |
| Tamsulosin Hcl | 262 | $3,603 |
| Silodosin | 34 | $3,064 |
| Estradiol | 30 | $2,310 |
| Trospium Chloride | 42 | $2,284 |
| Oxybutynin Chloride ErOxybutynin Chloride | 45 | $1,597 |
| Finasteride | 104 | $1,242 |
| Solifenacin Succinate | 20 | $697 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 41 | $599 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 51 | $541 |
| Acetic Acid | 19 | $186 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 20 | $103 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $118 | $34,16752 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $180 | $14,40523 claims |
| PfizerPremarin | $201 | $12,06128 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,127 physician assistant providers in Nebraska.
Other physician assistant in Omaha
- Kimberly GatesOmaha$109K
- Kandice DoleshOmaha$106K
- Kathryn KestiOmaha$34K
- Sarah GretemanOmaha$24K
- Christopher BeasleyOmaha$15K
- Corrine GiggeeOmaha$12K
- Austin DuerksenOmaha$12K
- Erin HoffmanOmaha$12K
- Sara MasonOmaha$12K
- Sally CampbellOmaha$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.